ArticleFrontiers in immunology2025

Senescence-associated signature based on immunotherapy response sequencing reveals PPIL3 as target for bladder cancer treatment and prognosis prediction.

Kaixuan Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.